LANSOPRAZOLE KRKA 30 mg, gastro-resistant capsule 14 capsules
Active ingredients: Lansoprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule14 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANSOPRAZOLE KRKA 30 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 14 gélule(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68266705CIP73899159CIP133400938991598Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANSOPRAZOLEgélule | 30 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.